缺血性卒中溶栓后颅内动脉瘤破裂致死:病例报告与文献回顾
本文报告一例已知颅内动脉瘤患者在急性缺血性卒中静脉溶栓后发生致命性蛛网膜下腔出血,回顾性发现其近期有既往未经历的头痛史,提示先兆出血。文献中另识别一例类似患者,作者据此提出对拟溶栓的动脉瘤患者应排除此类头痛病史。
要点
- 拟溶栓的动脉瘤患者应询问近期新发头痛史以排除先兆出血。
- 已知未破裂动脉瘤患者溶栓后颅内出血风险可能增加。
- 溶栓前头痛病史回顾性提示先兆出血,需警惕动脉瘤破裂风险。
核心结论
- 对拟行溶栓治疗的已知动脉瘤患者,应排除近期新发头痛史以提示先兆出血。
- 静脉溶栓后颅内出血风险在未破裂动脉瘤存在时可能增加。
研究设计与样本
- 病例报告并文献回顾,报告一例已知动脉瘤患者溶栓后致命性蛛网膜下腔出血。
- 文献中识别出另一例类似患者。
主要发现
- 患者溶栓后发生致命性蛛网膜下腔出血。
- 回顾性发现近期有既往未经历的头痛史,提示先兆出血。
临床怎么用
- 对拟溶栓的动脉瘤患者,应详细询问近期新发头痛史以评估先兆出血可能。
局限性
- 病例报告与文献回顾,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intravenous thrombolysis is a proven treatment of acute ischemic stroke. Its complications include intracranial hemorrhage; the risk may be increased in the presence of an unruptured aneurysm. We present a case report of a patient who suffered fatal subarachnoid hemorrhage after thrombolysis from a known aneurysm. A history of recent previously inexperienced headaches was revealed retrospectively, suggestive of sentinel bleedings. A similar patient was identified in the literature; we thus propose that this history should be excluded in patients harboring an aneurysm considered for thrombolytic treatment.
引用
- Beneš V, Jurák L, Jedlička J, et al. Fatal intracranial aneurysm rupture after thrombolytic treatment for ischemic stroke: a case report and literature review. Acta Neurochir (Wien). 2019. PMID: 31065893. doi:10.1007/s00701-019-03931-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。